SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026315
Filing Date
2018-11-02
Accepted
2018-11-01 18:01:17
Documents
51
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-10q_20180930.htm 10-Q 1134663
2 EX-31.1 cort-ex311_8.htm EX-31.1 15340
3 EX-31.2 cort-ex312_7.htm EX-31.2 15339
4 EX-32.1 cort-ex321_6.htm EX-32.1 6744
5 EX-32.2 cort-ex322_9.htm EX-32.2 6587
  Complete submission text file 0001564590-18-026315.txt   4112749

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cort-20180930.xml EX-101.INS 882666
7 XBRL TAXONOMY EXTENSION SCHEMA cort-20180930.xsd EX-101.SCH 33890
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20180930_cal.xml EX-101.CAL 44324
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20180930_def.xml EX-101.DEF 53851
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20180930_lab.xml EX-101.LAB 234259
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20180930_pre.xml EX-101.PRE 165587
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 181155012
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1